Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease
about
The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5qSpecificity and kinetics of interstrand and intrastrand bifunctional alkylation by nitrogen mustards at a G-G-C sequenceCytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseasesTherapy-related myeloid neoplasms - what have we learned so far?Therapy-related myeloid neoplasms: pathobiology and clinical characteristicsCurrent understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessmentLinkage mapping of the human CSF2 and IL3 genesEvaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline.Genetic markers on chromosome 7.Multicenter validation study of a transplantation-specific cytogenetics grouping scheme for patients with myelodysplastic syndromesOutcome of allo-SCT for women with MDS or AML occurring after breast cancer therapyA murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytesA prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemiaAssignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders.The process of leukemogenesisLong-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor StudyDetection of numerical chromosomal abnormalities in neoplastic hematopoietic cells by in situ hybridization with a chromosome-specific probe.The co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case reportCytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL)Using bioinformatic approaches to identify pathways targeted by human leukemogensCytogenetic and genetic pathways in therapy-related acute myeloid leukemia.Second cancers in patients with the Ewing sarcoma family of tumours.Haematology.MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia.Secondary hematological malignancies associated with temozolomide in patients with glioma.Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implicationsGenome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibilityImpact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation.Chromosomal assignment of the human erythropoietin gene and its DNA polymorphism.TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines.Preleukemia: one name, many meanings.Therapy-related myeloid malignancies in myeloma
P2860
Q24299187-F3AE1D28-B649-461E-B11B-2DE13B536234Q24544461-1D9D3B52-37E1-46D0-A3F0-8084CD187C0CQ24562724-3552F907-2E8E-47F2-BE95-3A6D406B1948Q28071318-63FBF20A-8F4D-40B3-AF4E-9FF8E73B7AA4Q28386366-8DCC6B32-44B9-4922-8F05-1E550E2E8C8BQ28396265-5CDCE0AB-46F0-400D-8911-057A00F7749BQ33245961-74DC9F88-4EC7-4BE3-8B5B-EDDD05957C6EQ33419927-218FB6F6-9DDA-4E26-8189-6A87B1B5A8E2Q33676661-18F3C395-D573-464D-86E6-8F6494A1EAB0Q33847018-79E4A718-F7F6-4F06-8648-931E13F86E80Q33928011-FC3027B6-1E86-407D-B6DC-7D46255B4F28Q34064832-1FC87BB8-1F14-499B-87F7-B4EA4CC5C3A2Q34166565-4A0B91FC-8A7C-463C-8FA6-B25D29BF6D64Q34204750-09599BD2-F960-4BB8-A78B-BAF057A764DBQ34619840-4880299E-AB2A-49EC-BCDD-C7DCC358A162Q34637442-BAEFE469-6AFF-4248-8864-DE19AF47ABCAQ35067402-70EEA39C-FD80-4365-B386-F75C3294687CQ35811388-5BC799CC-06F6-4495-B609-B70142E4BC81Q35892130-08D9698E-CFF7-4DD2-8C89-28B29E71184FQ35981436-F63F7A25-BE61-49D7-84AB-9A86EE1EDA52Q36126146-59B61CFB-2524-489D-95BC-850392E860ADQ36274109-7CA5A665-698F-41CC-AA4C-91BB9E2D9FE1Q36711750-A93CE7EB-9977-4B23-87E9-D0ED6917DEA8Q36723863-FEE5BE8C-D039-40DF-AD7A-1224212A1D62Q36787577-4FCA4A7D-8E17-430E-BACD-7617A10AAEDCQ36892587-3A2376F8-FEC0-479B-B4AF-E9CFC26DA333Q37187672-F0A46683-2AB8-4BE6-8C5A-F93A4DAA7BC5Q37195857-FD4BD502-33AA-4C08-8D9D-20767E286036Q37209075-D840B94F-E9EE-4232-BB83-4828C2D80BDDQ37345807-9FCB3CE9-AE7C-454E-856A-37DE4B9EA0CAQ37399458-D8245021-67EF-4DC4-B213-9A4AADB93E5BQ37677630-ACE83952-CC89-4520-8B29-8245D0D6C99CQ37683379-5D58B93B-E69B-4F19-AF4D-4B215E5E8016Q39209765-AE4A78AB-98C2-4D48-ABF2-6D1BF3FC3CAA
P2860
Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease
description
1981 nî lūn-bûn
@nan
1981 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Nonrandom chromosome abnormali ...... usly treated malignant disease
@ast
Nonrandom chromosome abnormali ...... usly treated malignant disease
@en
Nonrandom chromosome abnormali ...... usly treated malignant disease
@nl
type
label
Nonrandom chromosome abnormali ...... usly treated malignant disease
@ast
Nonrandom chromosome abnormali ...... usly treated malignant disease
@en
Nonrandom chromosome abnormali ...... usly treated malignant disease
@nl
prefLabel
Nonrandom chromosome abnormali ...... usly treated malignant disease
@ast
Nonrandom chromosome abnormali ...... usly treated malignant disease
@en
Nonrandom chromosome abnormali ...... usly treated malignant disease
@nl
P2093
P1433
P1476
Nonrandom chromosome abnormali ...... usly treated malignant disease
@en
P2093
H M Golomb
J D Rowley
J W Vardiman
P304
P407
P577
1981-10-01T00:00:00Z